MX2013001234A - Derivados deuterados de tandospirona como agonistas del receptor 5-hidroxitriptamina 1a. - Google Patents
Derivados deuterados de tandospirona como agonistas del receptor 5-hidroxitriptamina 1a.Info
- Publication number
- MX2013001234A MX2013001234A MX2013001234A MX2013001234A MX2013001234A MX 2013001234 A MX2013001234 A MX 2013001234A MX 2013001234 A MX2013001234 A MX 2013001234A MX 2013001234 A MX2013001234 A MX 2013001234A MX 2013001234 A MX2013001234 A MX 2013001234A
- Authority
- MX
- Mexico
- Prior art keywords
- receptor agonists
- derivatives
- tandospirone
- deuterated
- ht1a receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Abstract
La presente invención se refiere a nuevos derivados de los agonistas del receptor 5-HIT1A de serotonina de la Fórmula I y en particular a composiciones y métodos para uso terapéutico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201070349 | 2010-08-05 | ||
PCT/DK2011/050302 WO2012016569A1 (en) | 2010-08-05 | 2011-08-04 | Deuterated tandospirone derivatives as 5-ht1a receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2013001234A true MX2013001234A (es) | 2013-04-24 |
Family
ID=44512475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013001234A MX2013001234A (es) | 2010-08-05 | 2011-08-04 | Derivados deuterados de tandospirona como agonistas del receptor 5-hidroxitriptamina 1a. |
Country Status (5)
Country | Link |
---|---|
US (1) | US20130303497A1 (es) |
EP (1) | EP2601187A1 (es) |
BR (1) | BR112013002846A2 (es) |
MX (1) | MX2013001234A (es) |
WO (1) | WO2012016569A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013121440A1 (en) | 2012-02-13 | 2013-08-22 | Cadila Healthcare Limited | Process for preparing benzisothiazol-3-yl-peperazin-l-yl-methyl-cyclo hexyl-methanisoindol-1,3-dione and its intermediates |
US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
CA2919892C (en) | 2013-08-12 | 2019-06-18 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
AU2015290098B2 (en) | 2014-07-17 | 2018-11-01 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
AU2015336065A1 (en) | 2014-10-20 | 2017-05-04 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
IT201900000657A1 (it) | 2019-01-16 | 2020-07-16 | Procos Spa | Processo per la sintesi di gepirone |
US11266627B1 (en) | 2021-05-04 | 2022-03-08 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4356108A (en) | 1979-12-20 | 1982-10-26 | The Mead Corporation | Encapsulation process |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4507303A (en) | 1981-12-22 | 1985-03-26 | Sumitomo Chemical Company, Limited | Succinimide derivatives, compositions and method of use |
US5011841B1 (en) * | 1989-11-14 | 1994-09-06 | Pfizer | Treatment of depression |
US5330762A (en) | 1992-02-27 | 1994-07-19 | Alza Corporation | Tandospiaine antidepressive therapy |
JP2002020291A (ja) | 2000-06-30 | 2002-01-23 | Sumitomo Pharmaceut Co Ltd | 認知機能障害の治療剤 |
JP2003335678A (ja) | 2002-05-17 | 2003-11-25 | Sumitomo Pharmaceut Co Ltd | 神経因性疼痛治療薬 |
US20040002500A1 (en) | 2002-06-28 | 2004-01-01 | Fabre Kramer Pharmaceutical, Inc. | Methods for treating attention deficit disorder |
JP4677191B2 (ja) | 2004-02-16 | 2011-04-27 | あすか製薬株式会社 | 過敏性腸症候群処置剤 |
EP1743645A4 (en) | 2004-06-01 | 2012-11-14 | Hisamitsu Pharmaceutical Co | ADHESIVE PATCH |
WO2008044336A1 (fr) | 2006-10-11 | 2008-04-17 | Hisamitsu Pharmaceutical Co., Inc. | Préparation adhésive contenant un cristal |
TW201023912A (en) | 2008-12-05 | 2010-07-01 | Alcon Res Ltd | Pharmaceutical suspension |
-
2011
- 2011-08-04 WO PCT/DK2011/050302 patent/WO2012016569A1/en active Application Filing
- 2011-08-04 BR BR112013002846A patent/BR112013002846A2/pt not_active Application Discontinuation
- 2011-08-04 US US13/814,391 patent/US20130303497A1/en not_active Abandoned
- 2011-08-04 MX MX2013001234A patent/MX2013001234A/es not_active Application Discontinuation
- 2011-08-04 EP EP11748884.1A patent/EP2601187A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2012016569A1 (en) | 2012-02-09 |
US20130303497A1 (en) | 2013-11-14 |
EP2601187A1 (en) | 2013-06-12 |
BR112013002846A2 (pt) | 2016-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013001234A (es) | Derivados deuterados de tandospirona como agonistas del receptor 5-hidroxitriptamina 1a. | |
IN2014KN02601A (es) | ||
MX342161B (es) | Compuestos antagonistas selectivos de receptor nk-3 novedosos, composicion farmaceutica y metodos para utilizarse en trastornos transmitidos por receptores nk-3. | |
IN2014MN02598A (es) | ||
EA201390163A1 (ru) | Гетеробициклические производные в качетстве ингибиторов hcv | |
UA109010C2 (en) | MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY | |
IN2014CN04530A (es) | ||
IN2015DN01119A (es) | ||
MX354102B (es) | Derivados de bencimidazol-prolina. | |
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
UA108743C2 (uk) | Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази | |
GEP20156372B (en) | Pyridazinone compounds and their use as daao inhibitors | |
IN2014KN01075A (es) | ||
MX2012013274A (es) | Novedosos derivados de la pirimidina. | |
IN2012DN03182A (es) | ||
IN2015DN01151A (es) | ||
MX2013006418A (es) | Derivados de oxazolil-metileter como agonistas del receptor de alx. | |
MX2011006006A (es) | Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos. | |
MX2014004858A (es) | Compuestos de 3,4-diamino-3-ciclobuten-1,2-diona disustituidos utiles en el tratamiento de patologias mediadas por quimiocinas. | |
MX2011013032A (es) | Inhibidores de fosfatidilinositol 3-cinasa. | |
MX340033B (es) | Derivados heterobiciclicos como inhibidores del virus de la hepatitis c. | |
MX2013006420A (es) | Derivados de aminotriazol hidrolixado como agonistas del receptor de alx. | |
PH12015501175A1 (en) | Substituted pyridopyrazines as syk inhibitors | |
MX350862B (es) | Acidos de piperidinil naftilacetico. | |
MX2012010127A (es) | Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |